Cellectar Biosciences, Inc. (CLRB)
2025-06-30 | ||||
|---|---|---|---|---|
| Research and development | 2,389,801 | |||
| General and administrative | 3,647,728 | |||
| Total operating expenses | 6,037,529 | |||
| Loss from operations | -6,037,529 | |||
| Interest income | 88,020 | |||
| Gain (loss) on valuation of warrants | -501,598 | |||
| Total other income (expense) | 589,618 | |||
| Net loss | -5,447,911 | |||
| Earnings per share, basic | -3.39 | |||
| Earnings per share, diluted | -3.39 | |||
| Weighted average number of shares outstanding, basic | 1,608,799 | |||
| Weighted average number of shares outstanding, diluted | 1,608,799 | |||